Search
IDEAYA Biosciences Inc
IDYAAdd to Watchlist
31.230USD
-0.030-0.10%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.74BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of IDEAYA Biosciences Inc is 8.35, ranking 135 out of 389 in the Biotechnology & Medical Research industry. The average price target is 46.00, with a high of 79.00 and a low of 31.00.
Analyst Rating
Based on
17
analysts
Buy
Current Rating
52.500
Target Price
+68.11%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
IDEAYA Biosciences Inc
IDYA
17
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is IDEAYA Biosciences Inc's expected revenue for the next quarter?
IDEAYA Biosciences Inc's expected revenue is 5.19M.
What is IDEAYA Biosciences Inc's price target?
Analysts forecast that IDEAYA Biosciences Inc's price target is USD 46.00, with the highest forecast at USD 79.00 and the lowest forecast at USD 31.00.
How have IDEAYA Biosciences IncIDYA's recent earnings per share performed?
The market expectation was USD -1.11, while IDEAYA Biosciences IncIDYA's earnings per share (EPS) for the previous quarter was USD -0.94. EPS for the next quarter is expected at USD -1.07.
What is the analyst rating for IDEAYA Biosciences Inc?
Based on the ratings of IDEAYA Biosciences Inc's stock from 17 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
